Quick Answer
Zentalis Pharmaceuticals, Inc. reported Shares Outstanding of 69.09 million shares for fiscal year 2025.
Zentalis Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 69.09M | -3.1% |
| 2024 | 71.28M | +0.7% |
| 2023 | 70.77M | +19.4% |
| 2022 | 59.28M | +30.3% |
| 2021 | 45.49M | +10.8% |
| 2020 | 41.04M | +691.1% |
| 2017 | 5.19M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 72.25M | +1.5% | +0.2% |
| June 30, 2025 | 72.14M | +1.4% | +0.3% |
| March 31, 2025 | 71.95M | +1.3% | +0.9% |
| December 31, 2024 | 71.28M | +0.7% | +0.2% |
| September 30, 2024 | 71.15M | +0.7% | +0.1% |
| June 30, 2024 | 71.11M | +0.7% | +0.1% |
| March 31, 2024 | 71.01M | +19.5% | +0.3% |
| December 31, 2023 | 70.77M | +19.4% | +0.2% |
- Zentalis Pharmaceuticals, Inc. showed a decrease of -3.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, Zentalis Pharmaceuticals, Inc.’s shares outstanding has grown by 1231.8% (from 5.19 million shares to 69.09 million shares).
- The most recent figure is from Zentalis Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: